Smartlab Europe

Production & Manufacturing

Lonza’s Ibex Dedicate to Support the Commercial Manufacture of Kodiak’s KSI-301

We are committed to supporting Kodiak as they bring their highly innovative, sight-saving treatment option to patients with vision-threatening retinal diseases. Since 2014, we have been partnering with Kodiak to support the supply of KSI-301 drug substance for use...

Bionova Begins Construction of New Manufacturing Center

Bionova Scientific, a biologics CDMO with deep protein production, cell line development, process development and analytical expertise, has initiated construction of its new biologics manufacturing facility. Construction will be completed in approximately 10 months, with commissioning scheduled for Q3...

BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns

BD, a leading global medical technology company announced the formation of a strategic, public-private partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness...

Merck Opens its Largest M Lab Collaboration Center in Shanghai

Merck, a leading science and technology company, opened its M LabTM Collaboration Center in Shanghai, the company’s largest of nine centers worldwide. “With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase...

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies existing CDO partnership first established in 2018. “As we already have a track record of successful...

Tiziana announces agreement with STC Biologics for manufacturing of TZLS-501

Tiziana Life Sciences plc, a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, announces the execution of an agreement with STC Biologics, Inc. for GMP manufacturing of TZLS-501, an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody...

Cytiva upgrades Massachusetts contract biomanufacturing site with increased capacity and automation technologies

Cytiva, formerly part of GE Healthcare Life Sciences, is celebrating the completion of an extensive renovation to its Fast Trak cGMP contract biomanufacturing and process development site in Marlborough, Massachusetts, USA. The upgraded facility is 60,000 square feet (5,600...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »